Early Clinical Development

TFS has a long and successful track record in early or exploratory stage clinical trials from Phase 0 and I to Phase IIa.

Our expertise includes early proof-of-concept studies in special patient populations, as well as specialized technologies such as Position Emission Tomography (PET) imaging. Our close collaboration with state-of-the-art Phase I sites and clinics along with Global Key Opinion Leaders and Research Centers provide flexible, quality service solutions to meet each customer’s unique requirements.

TFS world class senior Medical and Clinical Advisors are available throughout the protocol development process. Upon protocol approval, our experienced project teams and full service solutions can take your trial from contract to report in less than six months (plus treatment period).

TFS has access to world-leading scientists and experience in conducting trials in healthy volunteers as well as special patient populations.

Early phase trials and special services include:

  • FTIM
  • Food-Drug interaction
  • Micro-dosing
  • Drug-Drug interaction
  • PET imaging
  • Pharmacokinetics
  • Pediatric populations
  • Oncology
  • Pharmacodynamics
  • Elderly populations
  • Bioequivalence
  • Orphan Indications
  • Biosimilar
  • Medical Device trials
  • PoC studies
  • First-in-Man
  • Bioanalytical

TFS offers customers efficient and flexible solutions for early phase projects and clinical pharmacology experienced project managers to handle your studies.